Recombinant Vaccine Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Recombinant Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.7% during the forecast period.

    This report presents the market size and development trends by detailing the Recombinant Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Recombinant Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Recombinant Vaccine industry and will help you to build a panoramic view of the industrial development.

    Recombinant Vaccine Market, By Type:

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    Recombinant Vaccine Market, By Application:

    • Human

    • Animal

    Some of the leading players are as follows:

    • Protein Science Corporation

    • Green Cross Corporation

    • Novartis AG

    • GlaxoSmithKline Plc

    • Bharat Biotech

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Subunit Recombinant Vaccines

      • 1.3.2 Attenuated Recombinant Vaccines

      • 1.3.3 Vector Recombinant Vaccines

    • 1.4 Market Segment by Application

      • 1.4.1 Human

      • 1.4.2 Animal

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Recombinant Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Vaccine by Major Types

      • 3.4.1 Subunit Recombinant Vaccines

      • 3.4.2 Attenuated Recombinant Vaccines

      • 3.4.3 Vector Recombinant Vaccines

    4 Segmentation of Recombinant Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Vaccine by Major End-Users

      • 4.4.1 Human

      • 4.4.2 Animal

    5 Market Analysis by Major Regions

    • 5.1 Global Recombinant Vaccine Production Analysis by Top Regions

    • 5.2 Global Recombinant Vaccine Consumption Analysis by Top Regions

    • 5.3 Global Recombinant Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Recombinant Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Recombinant Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Recombinant Vaccine Landscape Analysis

    • 7.1 North America Recombinant Vaccine Landscape Analysis by Top Countries

      • 7.1.1 United States Recombinant Vaccine Market Volume and Growth Rate

      • 7.1.2 Canada Recombinant Vaccine Market Volume and Growth Rate

      • 7.1.3 Mexico Recombinant Vaccine Market Volume and Growth Rate

    8. Europe Recombinant Vaccine Landscape Analysis

    • 8.1 Europe Recombinant Vaccine Landscape Analysis by Major Types

    • 8.2 Europe Recombinant Vaccine Landscape Analysis by Major End-Users

    • 8.3 Europe Recombinant Vaccine Landscape Analysis by Top Countries

      • 8.3.1 Germany Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.2 UK Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.3 France Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.4 Italy Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.5 Spain Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.6 Belgium Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.7 Poland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.8 Russia Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.9 Turkey Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.10 Netherlands Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.11 Portugal Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.12 Denmark Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.13 Finland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.14 Iceland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.15 Norway Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.16 Sweden Recombinant Vaccine Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Recombinant Vaccine Landscape Analysis

    • 9.1 Asia Pacific Recombinant Vaccine Landscape Analysis by Top Countries

      • 9.1.1 China Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.2 Japan Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.4 India Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.5 ASEAN Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.6 South Korea Recombinant Vaccine Market Volume and Growth Rate

    10 LAMEA Recombinant Vaccine Landscape Analysis

    • 10.1 LAMEA Recombinant Vaccine Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.2 Brazil Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.3 North Africa Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.4 South Africa Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.5 Argentina Recombinant Vaccine Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Protein Science Corporation

      • 11.1.1 Protein Science Corporation Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Green Cross Corporation

      • 11.2.1 Green Cross Corporation Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Novartis AG

      • 11.3.1 Novartis AG Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 GlaxoSmithKline Plc

      • 11.4.1 GlaxoSmithKline Plc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Bharat Biotech

      • 11.5.1 Bharat Biotech Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 104 Figures and 206 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Subunit Recombinant Vaccines

    • Figure Market Size and Growth Rate of Attenuated Recombinant Vaccines

    • Figure Market Size and Growth Rate of Vector Recombinant Vaccines

    • Figure Market Size and Growth Rate of Human

    • Figure Market Size and Growth Rate of Animal

    • Figure North America Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure United States Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure China Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure India Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Subunit Recombinant Vaccines

    • Figure Market Size and Growth Rate of Attenuated Recombinant Vaccines

    • Figure Market Size and Growth Rate of Vector Recombinant Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Human

    • Figure Market Size and Growth Rate of Animal

    • Table Global Recombinant Vaccine Production by Major Regions

    • Table Global Recombinant Vaccine Production Share by Major Regions

    • Table Global Recombinant Vaccine Consumption by Major Regions

    • Table Global Recombinant Vaccine Consumption Share by Major Regions

    • Table North America Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Europe Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table LAMEA Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table North America Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2014

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2018

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2026

    • Figure United States Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure France Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure China Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure India Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Science Corporation

    • Figure Sales and Growth Rate Analysis of Protein Science Corporation

    • Figure Revenue and Market Share Analysis of Protein Science Corporation

    • Table Product and Service Introduction of Protein Science Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross Corporation

    • Figure Sales and Growth Rate Analysis of Green Cross Corporation

    • Figure Revenue and Market Share Analysis of Green Cross Corporation

    • Table Product and Service Introduction of Green Cross Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech

    • Figure Sales and Growth Rate Analysis of Bharat Biotech

    • Figure Revenue and Market Share Analysis of Bharat Biotech

    • Table Product and Service Introduction of Bharat Biotech

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.